KW Wealth Management LLC Buys Shares of 2,677 UnitedHealth Group Incorporated $UNH

KW Wealth Management LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 2,677 shares of the healthcare conglomerate’s stock, valued at approximately $924,000. UnitedHealth Group comprises about 1.6% of KW Wealth Management LLC’s investment portfolio, making the stock its 19th biggest position.

A number of other institutional investors have also bought and sold shares of UNH. North Capital Inc. lifted its stake in shares of UnitedHealth Group by 16.2% in the 3rd quarter. North Capital Inc. now owns 194 shares of the healthcare conglomerate’s stock valued at $67,000 after purchasing an additional 27 shares during the period. Sunflower Bank N.A. lifted its stake in UnitedHealth Group by 1.5% in the third quarter. Sunflower Bank N.A. now owns 1,916 shares of the healthcare conglomerate’s stock valued at $662,000 after buying an additional 28 shares during the period. Abound Wealth Management grew its position in shares of UnitedHealth Group by 13.5% during the 3rd quarter. Abound Wealth Management now owns 244 shares of the healthcare conglomerate’s stock worth $84,000 after buying an additional 29 shares during the period. GK Wealth Management LLC lifted its position in shares of UnitedHealth Group by 7.2% during the 1st quarter. GK Wealth Management LLC now owns 506 shares of the healthcare conglomerate’s stock valued at $265,000 after acquiring an additional 34 shares during the period. Finally, Western Pacific Wealth Management LP grew its holdings in UnitedHealth Group by 12.0% in the second quarter. Western Pacific Wealth Management LP now owns 336 shares of the healthcare conglomerate’s stock worth $105,000 after purchasing an additional 36 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE UNH opened at $331.76 on Monday. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.82. The company has a fifty day moving average price of $333.71 and a 200-day moving average price of $319.16. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $606.36. The firm has a market cap of $300.52 billion, a price-to-earnings ratio of 17.32, a PEG ratio of 2.16 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. During the same period in the prior year, the firm posted $7.15 EPS. The firm’s quarterly revenue was up 12.2% compared to the same quarter last year. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th were given a $2.21 dividend. The ex-dividend date of this dividend was Monday, December 8th. This represents a $8.84 annualized dividend and a yield of 2.7%. UnitedHealth Group’s payout ratio is currently 46.14%.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of research analyst reports. Jefferies Financial Group increased their price objective on shares of UnitedHealth Group from $317.00 to $409.00 and gave the stock a “buy” rating in a research report on Friday, October 17th. Zacks Research upgraded UnitedHealth Group from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Wells Fargo & Company increased their target price on UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. KeyCorp upped their price objective on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. Finally, Royal Bank Of Canada boosted their target price on shares of UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 29th. Seventeen equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $385.54.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.